Shares of German defense sensor maker Hensoldt surged +15.3% on May 5 after the company posted a record first quarter, then flattened at €79.04 as markets digested a question that has dogged the stock for a year: whether the firm can actually build fast enough to cash in on Europe's defense spending boom.
• Q1 Orders Hit €1.5 Billion, More Than Double Last Year's €701 Million
Order intake reached €1,483 million, more than double the same period last year.
The main drivers were orders for the Schakal and Puma armored vehicle platforms and contract extensions for Eurofighter radar systems. For context, Q1 2025 intake was €701 million — meaning orders roughly doubled in twelve months. That pace matters because every euro booked today is a euro of future revenue locked in, reducing uncertainty for investors.
• A Nearly €10 Billion Backlog Gives Years of Visibility — If Production Follows
The record order book of nearly €10 billion provides what CFO Christian Ladurner called "excellent visibility" for further growth. Yet in 2025, new orders surged 62% while sales rose only modestly — a book-to-bill ratio of 1.9, meaning nearly twice as many orders flowed in as the company could fulfill. The company is spending around €1 billion through 2027 on new facilities, primarily in Germany, and plans to create 1,600 new jobs in 2026 — an 18% workforce expansion. Until those investments translate into shipped product, the backlog is a promise, not profit.
• Margins Are Expanding, Especially in Optics Equipment
Optronics adjusted EBITDA jumped from €1 million to €12 million, and the margin leapt from 1.3% to 12.2% — a sign that early factory investments are starting to pay off through higher output. For full-year 2026, management targets revenue of ~€2.75 billion and an adjusted EBITDA margin of 18.5%–19%.
• The Stock Is Still 30% Below Its Peak — Analysts Are Split
Deutsche Bank holds a "Buy" with a €101 target, while Barclays rates the stock "Equal Weight" at €95 and J.P. Morgan is "Neutral" at €85, flagging tight margin guidance. At €79, the market is pricing in execution risk. The next proof point: whether Q2 revenue confirms the factory ramp is real.